| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/11/2013 | EP2635608A1 Method for decontaminating starch hydrolysates for the preparation of glucose polymers for peritoneal dialysis |
| 09/11/2013 | EP2635589A1 Process for the preparation of phosphoric acid mono- (l-{4- [(s) -5- (acetylaminomethyl) - 2 - oxo - oxazolidin- 3 - yl]- 2, 6 - difluorophenyl} - 4 -methoxymethylpiperidin- 4 - yl) ester |
| 09/11/2013 | EP2635588A1 Condensed imidazolylimidazoles as antiviral compounds |
| 09/11/2013 | EP2635587A1 Novel 6-arylamino pyridone carboxamide as mek inhibitors |
| 09/11/2013 | EP2635584A1 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate |
| 09/11/2013 | EP2635581A1 7-([1,2,3]triazol-4-yl)-pyrrolo[2,3-b]pyrazine derivatives |
| 09/11/2013 | EP2635580A2 Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate |
| 09/11/2013 | EP2635579A1 Synthetic lethality in cancer |
| 09/11/2013 | EP2635578A1 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives |
| 09/11/2013 | EP2635577A1 Substituted 6-fluoro-1h-pyrazolo[4,3-b]pyridines and use thereof |
| 09/11/2013 | EP2635576A1 Benzyl-substituted carbamates and use thereof |
| 09/11/2013 | EP2635575A1 Carbazole and carboline derivatives, and preparation and therapeutic applications thereof |
| 09/11/2013 | EP2635574A1 1h-pyrrolo[2,3-b]pyridine derivatives |
| 09/11/2013 | EP2635573A1 Heterocyclic compounds as s1p1 agonists for the treatment of autoimmune and vascular diseases |
| 09/11/2013 | EP2635572A2 Compounds useful as modulators of trpm8 |
| 09/11/2013 | EP2635571A1 Novel inhibitors of hepatitis c virus |
| 09/11/2013 | EP2635570A2 Novel specific hcv ns3 protease inhibitors |
| 09/11/2013 | EP2635569A1 Crystalline forms of ( s ) - 2 - amino - 3 - (4 - ( 2 - amino - 6 - ( (r) - 1 - (4 - ch loro-2- (3 -methyl- 1h- pyrazol- 1 -yl) phenyl) - 2, 2, 2 - trifluoroethoxy) pyrimidin- 4 - yl) phenyl) propanoic acid |
| 09/11/2013 | EP2635567A1 Indole derivatives |
| 09/11/2013 | EP2635566A1 Benzimidazole inhibitors of leukotriene production |
| 09/11/2013 | EP2635565A1 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k- delta inhibitors |
| 09/11/2013 | EP2635563A1 Crystalline forms of hydrochloride salt of (4a-r,9a-s) -1- (1h - benzoimidazole- 5 -carbonyl) -2, 3, 4, 4a, 9, 9a - hexahydro -1h- indeno [2, 1 -b]pyridine- 6 -carbonitrile and their use as hsd 1 inhibitors |
| 09/11/2013 | EP2635562A1 Pyrrolidine derivatives used as cathepsin inhibitors |
| 09/11/2013 | EP2635560A1 Dihydrooxazol-2-amine derivatives |
| 09/11/2013 | EP2635559A2 Neurotrypsin inhibitors |
| 09/11/2013 | EP2635558A1 Process for preparing bendamus tine hydrochloride monohydrate |
| 09/11/2013 | EP2635557A2 Nicotinamides as jak kinase modulators |
| 09/11/2013 | EP2635554A2 Novel neurotrypsin inhibitors |
| 09/11/2013 | EP2635307A2 Pharmaceutical compositions |
| 09/11/2013 | EP2635303A2 Methods of treating rheumatoid arthritis using il-17 antagonists |
| 09/11/2013 | EP2635290A1 Novel self-assembling polyphenol-quinonoid polymer derivatives and uses thereof |
| 09/11/2013 | EP2635289A1 Peg or peg block copolymers for treating colorectal cancer |
| 09/11/2013 | EP2635288A1 Treatment of pituitary corticotroph tumors using r-roscovitine |
| 09/11/2013 | EP2635287A1 Administration of nedd8-activating enzyme inhibitor |
| 09/11/2013 | EP2635286A2 Methods for treating cancer |
| 09/11/2013 | EP2635285A1 Heteroaryl compounds and uses thereof |
| 09/11/2013 | EP2635284A1 Heterocyclic compounds and uses thereof |
| 09/11/2013 | EP2635283A2 Methods for treatment of brain injury utilizing biologics |
| 09/11/2013 | EP2635282A1 Compositions and methods for treating myelofibrosis |
| 09/11/2013 | EP2635281A1 Methods and compositions for prevention and treatment of cardiac hypertrophy |
| 09/11/2013 | EP2635280A2 Cytosine deaminase modulators for enhancement of dna transfection |
| 09/11/2013 | EP2635279A2 Chemical compounds |
| 09/11/2013 | EP2635278A2 Pesticidal compositions and processes related thereto |
| 09/11/2013 | EP2635277A1 Use of active pharmaceutical compounds for the treatment of central nervous system conditions |
| 09/11/2013 | EP2635276A2 Composition and method for treating skin conditions |
| 09/11/2013 | EP2635275A1 Gpr17-modulating compounds, diagnostic and therapeutic uses thereof |
| 09/11/2013 | EP2635274A1 Anti-staphylococcal celecoxib derivatives |
| 09/11/2013 | EP2635273A2 Isoflavonoid compositions and methods for the treatment of cancer |
| 09/11/2013 | EP2635272A1 Accordion pill comprising levodopa for an improved treatment of parkinson's disease symptoms |
| 09/11/2013 | EP2635271A1 Novel treatment of multiple sclerosis (ms) |
| 09/11/2013 | EP2635270A1 Methods of treatment using lipid compounds |
| 09/11/2013 | EP2635269A1 A combination composition |
| 09/11/2013 | EP2635268A1 Pharmaceutical combinations for the treatment of metabolic disorders |
| 09/11/2013 | EP2635267A2 Dynamic balancing of autonomic nervous system through vitamin mk-7 |
| 09/11/2013 | EP2635266A1 Composition and drug containing omega-3 fatty acids, and a modulator |
| 09/11/2013 | EP2635265A2 Novel low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery |
| 09/11/2013 | EP2635264A1 Formulations comprising polyethylene glycol |
| 09/11/2013 | EP2635263A1 A composition comprising s-[2-([[1-(2-ethylbutyl)-cyclohexyl]-carbonyl]amino)phenyl]2-methylpropanethioate and croscarmellose sodium |
| 09/11/2013 | EP2635262A2 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles |
| 09/11/2013 | EP2635260A2 Compositions and methods for the delivery of therapeutics |
| 09/11/2013 | EP2635256A1 A2a antagonists as cognition and motor function enhancers |
| 09/11/2013 | EP2635254A1 Compositions and methods relating to reduced mucoadhesion |
| 09/11/2013 | EP2635134A1 Carotenoid compositions containing octenyl succinate anhydride-modified gum acacia |
| 09/11/2013 | EP2635127A1 Combination therapy for prostate cancer using botanical compositions and bicalutamide |
| 09/11/2013 | EP2635124A1 Alkylsulfinyl-substituted thiazolide compounds |
| 09/11/2013 | EP2635123A1 Pesticidal compositions and processes related thereto |
| 09/11/2013 | EP2635122A1 Methods for inhibiting insect infestations |
| 09/11/2013 | EP2635121A1 Isoflavonoid compounds and methods for the treatment of cancer |
| 09/11/2013 | EP2635120A1 Compositions comprising oleuropeins and flavanoids and their use |
| 09/11/2013 | EP2635118A1 Articles incorporating absorbert polymer and ceragenin compound |
| 09/11/2013 | EP2319517B1 Use of prodrugs for ocular intravitreous administration |
| 09/11/2013 | CN1997354B Galenic formulations of organic compounds |
| 09/11/2013 | CN1867551B Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists |
| 09/11/2013 | CN1665807B Novel physiolgically active substances |
| 09/11/2013 | CN103298936A Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses |
| 09/11/2013 | CN103298928A Method for activating helper t cell |
| 09/11/2013 | CN103298837A Process for obtaining chondroitin sulphated at the 4- or 6- positions of n-acetyl-galactosamine residues |
| 09/11/2013 | CN103298825A Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size |
| 09/11/2013 | CN103298819A Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same |
| 09/11/2013 | CN103298818A Spiro-oxindole MDM2 antagonists |
| 09/11/2013 | CN103298817A Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 09/11/2013 | CN103298816A Substituted pyrazolo-quinazoline derivatives as kinase inhibitors |
| 09/11/2013 | CN103298815A Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate |
| 09/11/2013 | CN103298814A 2-anilinopurin-8-ones as inhibitors of TTK/MPS1 for the treatment of proliferative disorders |
| 09/11/2013 | CN103298812A Process for the preparation of tenofovir |
| 09/11/2013 | CN103298811A Diaza-spiro[5.5]undecanes useful as orexin receptor antagonists |
| 09/11/2013 | CN103298810A 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 09/11/2013 | CN103298809A 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
| 09/11/2013 | CN103298808A Novel ureas for the treatment and prevention of cancer |
| 09/11/2013 | CN103298807A Heterocyclic compounds as S1P1 agonists for the treatment of autoimmune and vascular diseases |
| 09/11/2013 | CN103298806A Substituted pyridazine carboxamide compounds |
| 09/11/2013 | CN103298805A Quinazoline compounds and methods of use thereof |
| 09/11/2013 | CN103298804A New chlorine e6-folic acid conjugated compound, preparation method thereof, and pharmaceutical composition containing the same for treatment of cancer |
| 09/11/2013 | CN103298803A Substituted pyridazine carboxamide compounds as kinase inhibitor compounds |
| 09/11/2013 | CN103298801A 4- (5-cyano-pyrazol-1-yl) -piperidine derivatives as GPR 119 modulators |
| 09/11/2013 | CN103298799A Heterocyclic compounds suitable for the treatment of dyslipidemia |
| 09/11/2013 | CN103298797A Method of preparation of metaxalone |
| 09/11/2013 | CN103298796A Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio) acetic acid and uses thereof |
| 09/11/2013 | CN103298795A Pure intermediate for preparing letrozole |
| 09/11/2013 | CN103298794A Pyridine compounds and aza analogues thereof as TYK2 inhibitors |